Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 11, 2025
DANDY® CELERY LAUNCHES “NATIONAL CELERY MONTH” SWEEPSTAKES
GlobeNewswire
·
March 11, 2025
Oviedo, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Dandy® Produce, a leading grower of fresh celery, radish and corn in the U.S., announces the launch of its “National Celery Month” Sweepstakes. Now through March 31, participants can enter HERE for 35 …
VIVUS تطلق عقار QSYMIA® في الإمارات العربية المتحدة
GlobeNewswire
·
March 11, 2025
- علاج جديد في مجال التحكم بالوزن أصبح متاحاً الآن - دولة الإمارات العربية المتحدة هي الدولة الأولى التي تطرح دواء QSYMIA في منطقة الشرق الأوسط - ارتفاع معدلات السمنة يكلّف الإمارات العربية المتحدة ما يقرب من 12 مليار دولار سنويًا كامبيل، كاليفورنيا, March …
Service Coordination Inc. Earns NBRI’s Prestigious Circle of Excellence Award
GlobeNewswire
·
March 11, 2025
FREDERICK, MD, March 11, 2025 (GLOBE NEWSWIRE) -- Service Coordination, Inc. (SCI) has been named a recipient of the National Business Research Institute (NBRI) Circle of Excellence Award, recognizing the organization’s outstanding Customer Experience and …
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
GlobeNewswire
·
March 11, 2025
HOUSTON, March 11, 2025 (GLOBE NEWSWIRE) -- As Baylor Genetics celebrates a decade of leadership at the forefront of genetic testing, it is set to exhibit its latest scientific studies in genetic testing at the 2025 ACMG Annual Clinical Genetics Meeting, …
Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025
GlobeNewswire
·
March 11, 2025
WOBURN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the development and commercialization of dermatological products, today announced that it will report financial results for the …
The Guardian Group, LLC announces Fellowship Trained Orthopaedic Surgeon: Wes Madsen, MD, QME
EIN Presswire
·
March 11, 2025
Dr. Wes Madsen has joined The Guardian Group as a Qualified Medical Evaluator (QME) in the specialties of Spine and Orthopaedic Surgery SANTA ANA, CA, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- Wes Madsen, MD, QME is a board-certified …
The Guardian Group, LLC announces Fellowship Trained Forensic Psychiatrist: Charletta Dennis, MD, QME
EIN Presswire
·
March 11, 2025
Dr. Charletta Dennis has joined The Guardian Group as a Qualified Medical Evaluator (QME) with exams locations across California in the specialty of Psychiatry SANTA ANA, CA, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- Charletta Dennis, MD is a …
The Guardian Group, LLC announces Fellowship Trained Pain/PM&R Specialist: Renuka Rudra, MD, QME
EIN Presswire
·
March 11, 2025
Dr. Renuka Rudra has joined The Guardian Group as a Qualified Medical Evaluator (QME) in the specialties of Pain Medicine and Physical Medicine …
Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence
GlobeNewswire
·
March 11, 2025
TAMPA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it has signed a binding Letter of Intent (LOI) to acquire 100% of …
HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle
GlobeNewswire
·
March 11, 2025
DRAPER, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation today announced the first recipients of grants from their inaugural grant cycle, and the application timeline for their next grant cycle. This marks a significant step …
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
GlobeNewswire
·
March 11, 2025
BOSTON, March 11, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics, today announced …
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
GlobeNewswire
·
March 11, 2025
NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the launch of its Parent and Child Well-being offering, designed to support and alleviate stress for …
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
GlobeNewswire
·
March 11, 2025
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company …
AMPS Launches ClaimInsight: A Next-Generation Payment Integrity Suite Built for Accuracy, Speed, and Value
GlobeNewswire
·
March 11, 2025
PHOENIX, March 11, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (AMPS), a leader in healthcare cost containment and payment integrity solutions, today announced the launch of ClaimInsight, a cutting-edge payment integrity platform engineered …
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
GlobeNewswire
·
March 11, 2025
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a comprehensive brand evolution designed to unify its brand …
G-Flipons promise to improve the therapeutic efficacy of RNA editing
EIN Presswire
·
March 11, 2025
The paper resolves many unanswered questions about the recoding of RNAs by ADAR1 and the outcomes produced in a cell CHARLESTOWN, MA, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- The double-stranded RNA editing enzyme ADAR1 offers excellent …
AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
GlobeNewswire
·
March 11, 2025
On-demand video webcast now available Includes latest updates on pancreatic cancer and bird flu clinical trials OCALA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced its …
GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule
GlobeNewswire
·
March 11, 2025
LA JOLLA, CA, March 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
GlobeNewswire
·
March 11, 2025
• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities. WEXFORD, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- …
Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)
GlobeNewswire
·
March 11, 2025
DOYLESTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …